Yano T, Yokoyama H, Inoue T, Takanashi N, Asoh H, Ichinose Y
Department of Chest Surgery, National Kyushu Cancer Center, Fukuoka, Japan.
Oncology. 1994 Nov-Dec;51(6):507-9. doi: 10.1159/000227394.
To examine the efficacy of bleomycin on the local control of malignant pericardial effusion, we prospectively conducted a clinical trial consisting of continuous pericardial drainage and a local instillation of bleomycin. In the current study, we treated 7 patients, who suffered from malignant pericardial effusion with cardiac tamponade due to advanced-stage non-small cell carcinoma of the lung. The pericardial effusions were continuously drained through an echo-guided inserted catheter. After the effusions were drained as completely as possible, 5 mg of bleomycin were instilled locally via the catheter. In all patients but one, the draining catheter could be successfully removed. The duration of drainage ranged from 4 to 13 days (mean: 9.2 days). Five of the 7 patients achieved a complete remission of pericardial effusions, which was maintained until death or the last day of follow-up. Intrapericardial bleomycin treatment was thus found to be effective on malignant pericardial effusions without any adverse effects. However, a further study comparing the effect of pericardial instillation of bleomycin versus drainage alone would be needed for the determination of the usefulness of bleomycin.
为了研究博来霉素对恶性心包积液局部控制的疗效,我们前瞻性地开展了一项临床试验,该试验包括持续心包引流和局部注入博来霉素。在本研究中,我们治疗了7例因晚期非小细胞肺癌导致恶性心包积液并伴有心脏压塞的患者。通过超声引导插入导管持续引流心包积液。在积液尽可能完全引流后,经导管局部注入5毫克博来霉素。除1例患者外,所有患者的引流导管均可成功拔除。引流持续时间为4至13天(平均9.2天)。7例患者中有5例心包积液完全缓解,直至死亡或随访的最后一天仍保持缓解。因此发现心包内注入博来霉素对恶性心包积液有效且无任何不良反应。然而,为了确定博来霉素的有效性,还需要进一步研究比较心包内注入博来霉素与单纯引流的效果。